Trial intelligence / Profile preview

US vs Laparoscopic TAP Block in Colorectal Surgery

NCT02538679Completed

Sponsor
Cedars-Sinai Medical Center
Start
Aug 2015
Primary completion
Apr 2017
Modality
Small Molecules
01

Overview

Randomised, single-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Analgesic requirement in morphine equivalents at 24 hours. Started Aug 2015; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02538679.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02538679.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call